Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections as Cases are on the Rise Pharmaceutical Investing
Premier Health Announces the Appointment of Giovanni Garay as Ontario General Manager Medical Device Investing
Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 at the Association for Research in Vision and Ophthalmology Annual Meeting Pharmaceutical Investing
Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference Pharmaceutical Investing
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Bausch Health Companies Investigation Pharmaceutical Investing
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months Pharmaceutical Investing
Bausch Health Companies Inc. Will Release First-Quarter 2022 Financial Results On May 10 Pharmaceutical Investing
Medtronic and GE Healthcare announce a collaboration to meet growing need for outpatient care Medical Device Investing
GE Healthcare and Medtronic Announce a Collaboration to Meet Growing Need for Outpatient Care Medical Device Investing
